Gotham Asset Management »

Eyepoint Pharmaceuticals shares owned by Gotham Asset Management

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Gotham Asset Management from 13F filings

Historical chart of Gotham Asset Management investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Gotham Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Gotham Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $304k 13k 23.11

More positions owned by Gotham Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tidal Etf Tr Gotham Enhncd (GSPY)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Snowflake Cl A (SNOW)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Tidal Etf Tr Gotham 1000 Valu (GVLU)
Amazon (AMZN)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Core Msci Emkt (IEMG)
Broadcom (AVGO)
Johnson & Johnson (JNJ)

View all positions for Gotham Asset Management

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Franklin Resources
T. Rowe Price Associates
Vanguard Group
Citadel Advisors
Perceptive Advisors
Millennium Management
Ikarian Capital
Deutsche Bank Aktiengesellschaft
Federated Investors
Fiera Capital Corporation
Laurion Capital Management
Susquehanna International
First Turn Management
UBS Group

View all funds holding Eyepoint Pharmaceuticals